Johnson Sigmond G, Gunnet Joseph W, Moore John B, Miller William, Wines Pam, Rivero Ralph A, Combs Don, Demarest Keith T
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., 1000 Rt. 202, PO Box 300, Raritan, NJ 08869, USA.
Bioorg Med Chem Lett. 2006 Jul 1;16(13):3362-6. doi: 10.1016/j.bmcl.2006.04.017. Epub 2006 May 2.
A series of 1,3-disubstituted cyclohexylmethyl urea and amide derivatives were synthesized as motilin receptor antagonists. Starting from known motilin antagonists, 1a and 1b, the cyclopentene scaffold was replaced and the four recognition elements optimized to arrive at a potent novel series.